Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
Researchers at the University of Kentucky are working on a potential diagnostic test for Alzheimer's disease, based on biomarkers in cerebrospinal fluid.
Scout Diagnostics, a company targeting early diagnosis of Alzheimer's disease, recently received matching funds of $435,600 to support developing a laboratory test to detect and confirm Alzheimer's disease in its earliest stages. Scout was formed in 2006 by University of Kentucky chemistry professors and Sanders-Brown Center on Aging researchers Mark Lovell and Bert Lynn, along with CEO John Beran.
Lovell and Lynn have been working for some time with biomarkers for Alzheimer's disease. They have identified specific markers for Alzheimer's in cerebrospinal fluid. The potential exists for researchers to develop a diagnostic test for early Alzheimer's using analysis of spinal fluid samples.
This would be a significant development, as existing treatments for Alzheimer's diseaseare most effective if started extremely early in the progression of the disease — often before clinical signs of cognitive impairment are apparent.
The UK Sanders-Brown Center on Aging also maintains a large cohort of research volunteers, many of whom have donated cerebrospinal fluid for research on the diagnostic test. Read more: dailymail.co.uk
The potential health conditions of the L-carnitine
L-Carnitine, a vitamin-like nutrient, occurs naturally in the human body and is essential for turning fat into energy. It is frequently used as a dietary supplement by physically active people to help with post-exercise recovery. Read more: nutraingredients-usa.com
No comments:
Post a Comment